Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2025 Oct 22;19(10):e0013657. doi: 10.1371/journal.pntd.0013657

Entomological surveys and insecticide resistance in the dengue vector Aedes aegypti in Dakar, Senegal: First detection of the kdr mutation

Ndeye Marie Sene 1,*, Shirley Nimo-Paintsil 2, Moussa Gaye 1, El Hadj Ndiaye 1, El Hadji Malick Ngom 1, Babacar Diouf 1, Faty Amadou Sy 1, Moussa Moise Diagne 3, Alioune Gaye 1, Diawo Diallo 1, Ibrahima Dia 1, Scott C Weaver 4, Samuel Dadzie 5, James F Harwood 6, Mawlouth Diallo 1
Editor: Clarence Mang'era7
PMCID: PMC12561948  PMID: 41124290

Abstract

Aedes aegypti is the primary vector of arboviruses in Senegal, yet this species is not typically targeted by routine vector control programs. Through entomological surveillance, we investigated over a one-year (2022–2023) the risk of arbovirus transmission in Dakar, Senegal, the spatial distribution of insecticide resistance and the underlying resistance mechanisms. Weekly ovitraps were deployed in 15 localities (10 per locality), and monthly adult mosquito collections were conducted in six localities. Arboviruses were detected in adult Ae. aegypti using Real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR) and positive sample were sequenced for phylogenetic analysis to determine the genetic diversity. Blood-feeding preferences and resting behaviors were assessed, and WHO tube bioassays evaluated susceptibility to pyrethroids, organophosphates, and carbamates. Molecular screening targeted knockdown resistance (kdr) mutations (F1534C, V1016G/I, S989P). Ovitrap positivity peaked between August and October, coinciding with the rainy season. Ae. aegypti was detected in all surveyed localities, and dengue virus (DENV) was found in adult mosquitoes between September and December 2022, confirming active transmission risk. Females predominantly fed on humans and were found resting both indoors and outdoors. All tested populations were resistant to permethrin and bendiocarb, with suspected resistance to malathion. kdr mutations of F1534C (CC, FC), V1016G (VG), S989P (SP, and PP) were detected. These findings demonstrate a substantial entomological risk of arbovirus transmission in Dakar, characterized by high vector density, confirmed DENV infection, and widespread insecticide resistance. In this study, we detected three kdr mutations (F1534C, V1016G, and S989P), while previous studies in Senegal have documented metabolic resistance mechanisms. Together, these resistance mechanisms may compromise the efficacy of vector control strategies. Integrated vector management combining rational insecticide use, source reduction, and innovative control tools is recommended for sustainable Aedes-borne disease control in Senegal.

Author summary

Weekly ovitrap indices and monthly adult parameters of Ae. aegypti were evaluated in 15 neighborhoods of Dakar, Senegal, over a one-year (2022–2023). The spatial distribution of insecticide resistance, the blood-feeding preferences, the underlying mechanisms and arboviruses infection on this vector were also investigated. The highest proportions of homes with Aedes-positive traps were observed between August and October. Aedes aegypti was found in all surveyed sites. DENV was detected in Ae. aegypti collected between September and December 2022. Mosquito populations from all sites exhibited resistance to the newly developed WHO diagnostic insecticide doses for Aedes mosquitoes. Low frequencies of the kdr mutations 1534C, V1016G, and 989P were identified. The study highlighted the risk of Aedes-borne disease outbreaks during the rainy season in Dakar. Multiple insecticide resistance mechanisms detected in the study populations could impact the effectiveness of control measures. Improving sanitation should be considered alongside insecticide-based strategies for Ae. aegypti control in the study areas.

Introduction

Aedes aegypti is the primary urban vector of several arboviruses, including dengue, Zika, chikungunya, and yellow fever. In Senegal, it is responsible for all urban outbreaks in recent years, particularly in the capital Dakar [1]. Despite its major role, data on the species bioecology remain limited [2]. In recent years, dengue has emerged as a significant public health concern in Senegal. Major outbreaks occurred between 2017 and 2019 in several regions including Dakar, Touba, Fatick, Louga, and Saint-Louis, with over 420 confirmed cases [3], followed by another outbreak in Rosso in 2021, with more than 100 confirmed cases [4]. Globally, dengue is one of the most significant re-emerging infectious diseases [5]. Its etiologic agent, dengue virus (DENV), belongs to the Orthoflavivirus genus and comprises four distinct serotypes (DENV-1 to DENV-4). While DENV-2 circulates in a sylvatic cycle in Africa involving monkeys and Aedes species, all four serotypes can be transmitted in urban settings by Ae. aegypti [2]. The distribution and expansion of arboviruses and their vectors are influenced by both environmental and anthropogenic factors. However, in Senegal, data on the bioecology of Ae. aegypti particularly its biting behavior and resting patterns remain limited.

Given the no specific treatment or commercially available vaccine for dengue and other Ae. aegypti-borne diseases in many regions, vector control remains the most effective tool to prevent and mitigate potential outbreaks. Developing an efficient vector control tool against this species is a major challenge for health authorities in Senegal. Currently, the emergency vector control interventions primarily involve space spraying of pyrethroids during dengue outbreaks in urban areas [6,7]. In some instances, larval source management and public awareness campaigns have also been implemented. These measures are often deployed reactively and lack long-term integration into routine control programs. However, the emergence and spread of insecticide resistance in Ae. aegypti could severely compromise the effectiveness of these strategies. Previous studies have reported resistance to multiple classes of insecticides, including pyrethroids, organophosphates, and carbamates. For instance, Dia et al. (2012) [6] first documented signs of resistance to permethrin in Dakar, and later Sene et al. (2021) [7], confirmed broader resistance patterns and explored underlying mechanisms in Ae. aegypti populations across Senegal. These findings raise significant concerns about the sustainability and efficacy of current insecticide-based control efforts. While the continued use of pyrethroids may appear suboptimal given the growing evidence of resistance, characterizing the presence and distribution of kdr mutations remains important for informing vector control strategies. Different kdr mutations can vary in their impact on resistance intensity, and combinations of mutations may further elevate resistance levels. Moreover, resistance is often heterogeneous across space and time. Therefore, spatiotemporal surveillance and kdr genotyping are valuable tools to guide adapted, evidence-based interventions, particularly in the context of outbreak response. Resistance mechanisms in Aedes mosquitoes worldwide generally involve target-site mutations and metabolic detoxification [8,9]. Several knockdown resistance (kdr) mutations have been identified as resistance markers in Aedes mosquitoes globally [10].

In Senegal, previous studies reported the total absence of kdr mutations (S989P, F1534C, V1016G/I), suggesting that, Ae. aegypti populations mainly rely on metabolic resistance mechanisms involving detoxification enzymes [7]. However, some of these mutations, such as F1534C and V1016I, are present in several populations in neighboring countries, including Burkina Faso, Côte d’Ivoire, Cape-Verde, Niger, and Mauritania [1115]. The V1016G and S989P mutations, first described in Ae. aegypti populations from Asia, have been reported in several African countries, including Benin and Mauritania indicating a possible geographic spread of these resistance [13,16]. These mutations have been associated with strong resistance to pyrethroids, particularly when combined with other kdr mutations such as F1534C, highlighting the importance of monitoring them in African Ae. aegypti populations. It is possible that these mutations are also present in Senegal populations but due to limited surveillance efforts, they have yet to be detected. Furthermore, the co-occurrence and potential synergistic effects of different kdr mutations can elevate resistance intensity and reduce the efficacy of insecticide-based interventions. Therefore, molecular surveillance of kdr mutations, alongside phenotypic resistance monitoring, remains valuable for adapting vector control strategies to local resistance profiles and for optimizing the use of available insecticides. The coexistence of kdr mutations and metabolic resistance mechanisms, has been widely documented in Ae. aegypti populations across Southeast Asia, sub-Saharan Africa and Latin America [1720]. The detection of such combinations in Senegal is therefore particularly concerning for the efficacy of current pyrethroid-based control strategies.

Vector control strategies should be guided by longitudinal bio-ecological data on Ae. aegypti (host-seeking, resting and feeding behaviors, infection patterns, insecticide susceptibility) in urban areas where outbreaks occur. In Senegal, such data remain limited particularly, in the capital, Dakar.

The objectives of this study were to: (i) establish baseline data on the distribution and behavior of Ae. aegypti populations, including egg density over space and time, host-seeking, host-preferences, and resting behavior; (ii) assess the infection rates of collected mosquitoes with arboviruses; and (iii) characterize the insecticide resistance status and resistance mechanisms in the populations across various study sites.

Materials and methods

Ethics statement

These studies performed through the NIH and AFHSD/GEIS projects were conducted in accordance with the guidelines established by the Senegalese Ministry of Health. This study was approved by the Comité National d’Ethique pour la Recherche en Santé (CNERS) (N°000089 and 000027/MSAS/ DPRS/CNERS), SEN20/08, approved on June 2021 and February 2023. The study protocol was carefully explained to the chief and inhabitants of each neighborhood investigated to obtain their informed oral consent. Informed oral consent was also obtained from the heads of each household in which mosquito samples were collected.

Study area

An entomological surveillance system was implemented in Dakar (14° 45’ 52.215“ N 17° 21’ 57.703” W). Dakar, the most populated city in Senegal with 3,896,564 inhabitants, lies at the westernmost point of continental Africa. Highly urbanized, it is characterized by wooded savannah vegetation and a climate with two distinct seasons: a hot and humid rainy season from June to October and a dry season from November to May. The mean annual temperature is approximately 27˚C, with total annual rainfall between 300- and 600-mm. Relative humidity varies between 52% in December and 75% in August.

Administratively, Dakar is divided into five districts: Dakar, Guédiawaye, Pikine, Rufisque and Keur Massar. Mosquito sampling was conducted in 15 localities spanning four of these districts: Dakar (Liberté, Point E, Grand Dakar, Ngor, Ouakam, Yoff, Grand Yoff, Médina, Plateau, Parcelles and Hanne village), Guédiawaye (Guédiawaye), Pikine (Mbao and Pikine) and Keur Massar (Keur Massar). Collections were performed during both the rainy (June to October) and the dry season (November to May), covering a full annual cycle from July 2022 to August 2023 (Fig 1).

Fig 1. Map of the city of Dakar showing the study sites.

Fig 1

This map was created using the R software (version 4.4.0) and the package raster using an empty shapefile from the HDX website (https://data.humdata.org/dataset/senegal-administrative-boundaries) available under Creative Commons Attribution 4.0 International licence.

Ovitrap surveillance

Ovitrap surveys were conducted weekly following the epidemiological weeks (standardized weekly reporting periods defined by the World Health Organization, beginning with the first week of the year that includes at least four days of January) from July 2022 to August 2023 in 15 localities. In each locality, 10 houses were selected, resulting in a total of 150 ovitraps deployed. The ovitraps consisted of 0.5 L black plastic containers placed 1.5 m above the ground inside randomly selected houses, following informed consent from the homeowners. Each ovitrap was filled with water and included a wooden stick serving as an oviposition substrate. Oviposition sticks were collected and replaced weekly, and eggs were counted under a stereomicroscope.

Adult mosquito sampling

Adult mosquitos’ collections were conducted monthly from August 2022 to July 2023 in six selected localities (Médina, Ouakam, Point E, Grand Yoff, Guédiawaye and Mbao). These localities were selected based on logistical feasibility (including trained personnel, laboratory capacity for resistance testing and virus screening, and frequent maintenance of traps). For egg collection, a large number of sites were selected since the monitoring was delegated to trained local agents. However, a limited number of localities were selected for adult collection because the activities were conducted by entomological teams from the Institut Pasteur de Dakar (IPD). The selected localities also reflect diverse urban typologies and ensure geographic and ecological representativeness across the three main administrative districts of Dakar (Dakar district: Médina, Ouakam, Point E, and Grand Yoff - Guédiawaye district: Guédiawaye - Pikine district: Mbao). Grand Yoff and Guédiawaye are lively, densely populated areas with informal housing. Mbao blends urban life with semi-rural and industrial zones. Médina, Dakar’s oldest neighborhood, is culturally rich but crowded. Ouakam combines a traditional fishing village with modern developments. Point E is an upscale area with reliable infrastructure.

Host-seeking mosquitoes were collected using Biogents (BG-Sentinel) traps baited with a chemical lure (BG-Lure: attractant designed to mimic human skin odors) and CO₂.The lure was replaced every four weeks in accordance with the manufacturer’s recommendations to maintain effectiveness during the study period.

In each locality, one house was selected among those where ovitraps were set up. Two traps were deployed (one indoor and one outdoor) in each house for three consecutive days. Collection bags were retrieved and replaced twice daily early in the morning at 07:00 a.m. and 07:00 p.m., to separate day and night collections. The outdoor traps were positioned in shaded and sheltered areas such as covered verandas or courtyards, protected from direct sun and rain, to optimize trap efficiency and mimic natural environments for Ae. aegypti. However, the indoor traps were placed in the bedrooms. Resting mosquitoes were sampled using a Prokopack aspirator in three houses per locality. Collections were conducted at equal time for 10 min indoor (bedrooms) and outdoor (semi-enclosed spaces such as corridors and courtyards within the house compound).

After collection, adult mosquitoes were immobilized on ice in the field. Mosquitoes were then transported in cool boxes to the laboratory, where they were killed and stored at −80 °C until further processing. Morphological identification was performed on a chill table to prevent RNA degradation. All mosquitoes collected were identified using standard morphological keys [21,22] and then pooled according to species, sex, feeding status (unfed and blood-fed), locality, method and date of collection. Number of unfed Ae. aegypti per pool ranging from 1 to 20 maximum while Ae. aegypti blood-fed was pooled individually. and 160 for the other species. Only Ae. aegypti, the unique vector identified was tested for virus detection. Other mosquito species were identified and pooled to document the biodiversity and for potential future analyses. Each pool of Ae. aegypti mosquitoes (whole mosquitoes for non-engorged and heads and thoraxes for engorged females) was homogenized in L-15 medium (GibcoBRL, Grand Island, NY, USA) for RNA extraction and arbovirus detection. For engorged females, the abdomens were homogenized in Phosphate-Buffered Saline (PBS), and the homogenate was used to determine the origin of their blood meals.

Detection of arboviruses in Aedes aegypti by real-time RT-PCR

To screen for arboviruses (Flaviviruses and Alphaviruses), Ae. aegypti pools were homogenized in 1.5 ml cryogenic vials containing 500 μl of L-15 medium (GibcoBRL, Grand Island, NY, USA) using sterile pestles in a biosafety level 2 laboratory. Homogenates were centrifuged at 8,000 rpm for 10 minutes at 4°C to remove mosquito debris. These were subsequently combined into super pools (collecting 50 μl of supernatant per pool) stratified by physiological status (blood-fed vs. unfed) and sex. Each super pool combined 12–14 pools contained 600–700 μl of supernatant for RNA extraction. After RNA extraction, 100 μl of supernatant from each super pool was processed using the QiaAmp Viral RNA Extraction Kit (Qiagen, Heiden, Germany), following the manufacturer’s instructions.

After viral RNA extraction, the super pools were tested for pan-Flaviviruses and pan-Alphaviruses using real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) on a Bio-Rad CFX96 instrument with SYBR Green-based melting curve analysis. Detection of Alphaviruses was performed as described in Vina-Rodriguez A et al. (2017), with a slight modification [23]. The QuantiTect SYBR Green RT-qPCR kit (QIAGEN, Hilden, Germany) was used for amplification, with dengue and chikungunya viruses serving as positive controls (Cq ≈ 28), supplied at the Centre de Recherche sur les Arbovirus (CRORA) biobank [24]. Pools within each positive super pool were subsequently tested individually for Flavivirus and Alphavirus. Furthermore, sequencing was performed on positive pools to identify specific viruses. Male mosquitoes were included in the screening to detect potential vertical transmission of arboviruses. For females, fed and unfed were pooled separately to detect infected (maybe infectious) vs infectious females.

Next-generation sequencing and genome assembly

RNA extracts from Flaviviruses-positive mosquito pools were processed to obtain complete genomes using a target enrichment standard hybridization approach with the Twist Biosciences Comprehensive Viral Research Panel (CVRP) [25]. This sequencing was conducted for phylogenetic analysis and determine the genetic diversity. The enriched sample libraries were prepared according to Twist Technical Support recommendations and subsequently loaded onto an Illumina iSeq 100 sequencing system, following the manufacturer’s guidelines. Raw sequencing data were generated in fastq format, and genome assembly was performed using the CZ-ID platform, an open-source metagenomics tool available at https://www.twistbioscience.com/sites/default/files/resources/2020-11/ProductSheet_NGS_ComprehensiveViralResearchPanel_11Nov20_Rev1.0.pdf, as already described [26,27].

Phylogenetic analysis

Sequence alignment was performed using MAFFT [28], and the alignment was further processed with IQ-TREE [29]. A maximum-likelihood (ML) phylogenetic tree was then constructed and visualized with Figtree V1.4.4 [30].

Blood feeding patterns of Aedes aegypti

The blood-fed female mosquitoes used to calculate the anthropophilic rate (AR) were collected using both BG-Sentinel traps and aspiration, as described above.

The origin of blood meals from engorged female mosquitoes of Ae. aegypti was determined using a modified Enzyme-Linked ImmunoSorbent Assay (ELISA) protocol originally described by Beier et al. [31]. Polyclonal anti-IgG antibodies were used to detect host-specific immunoglobulins from vertebrate species commonly present in urban environments, including humans, pigs, horses, sheep, cats, dogs, rats, cattle, rabbits, and chickens.

Insecticide resistance assessment in Aedes aegypti samples from Dakar

Insecticide susceptibility tests were conducted following WHO guidelines [32] on 3–5-day-old non-blood-fed F1 Ae. aegypti females. The eggs (F0) used for these tests come from the ovitraps described above. In order to limit the presence of many inbreeding in the populations tested, eggs were collected over several weeks and were mixed. This method ensures that the females tested represent a genetically diverse sample. Eggs were reared under laboratory (controlled conditions) until adult emergence. These adults were then allowed to mate, and the resulting F1 generation was used for the bioassays. The bioassays were performed under controlled conditions: 25°C (± 2°C) and 70% (±10%) relative humidity. Four replicates of 20–25 females per tube were exposed to each insecticide for 1 hour. The Vector Control Research Unit, Universiti Sains Malaysia (WHO collaborating Centre) provided all insecticide-impregnated papers used in this study. Tested insecticides papers included: pyrethroids (0.4% and 3.75% permethrin, 0.03% and 0.25% deltamethrin, 0.08% and 0.25% lambda-cyhalothrin, 0.08% and 0.25% alpha-cypermethrin), carbamates (0.2% bendiocarb) and organochlorines (1.5% malathion, 60 mg/m2 pirimiphos-methyl and 1.0% chlorpyriphos-ethyl). The lower concentrations used correspond to the WHO-recommended new diagnostic doses for assessing Aedes susceptibility. The higher concentrations (pyrethroids 3.75% permethrin, 0.25% deltamethrin 0.25% lambda-cyhalothrin and 0.25% alpha-cypermethrin) are not currently the standard for Aedes but are usually applied in Anopheles intensity essay. They were used here due to the availability of pre-impregnated papers and to provide initial data one the populations under study. Papers impregnated with olive oil (for organophosphate and carbamate control), and silicone oil (for pyrethroid control) were used as control. For pyrethroids, cumulative knockdown rates were recorded after 10, 20, 30, 40, 50, 60, 70 and 80 min. After 1-hour exposure period, mosquitoes were transferred to holding tubes, provided with 10% sugar solution, and kept at 25°C (± 2°C) and 70% (±10%) relative humidity. Mortality was recorded at 24-hours post-exposure.

Genotyping of kdr mutations in Aedes aegypti populations

A subsample of 1,014 Aedes mosquitoes, phenotypically classified as resistant or susceptible to insecticides (0.4% permethrin, 0.03% deltamethrin, 0.08% lambda-cyhalothrin, 0.08% and alpha-cypermethrin) based on bioassay results, was randomly selected for genotyping of the kdr mutations F1534C, S989P, V1016I and V1016G. A maximum of 26 mosquitoes per insecticides (alive or dead) were genotyped. When fewer than 26 mosquitoes were available, all were included in the analysis. A total of 536 resistant Ae. aegypti mosquitoes and 479 susceptible mosquitoes representing mosquitoes from all the six study neighborhoods were used for the genotyping. Total DNA was extracted from whole mosquitoes using the CTAB 2% [33]. Kdr mutations were detected using allele-specific PCR according to the protocols of Saavedra-Rodriguez et al [34] and Bariami et al [35]. The single 10 μL volume reaction contained 2.5 μL of DNA sample, 5 μL of Luna Universal qPCR Master Mix (SuperMix), 1.3 μl of sterile water, 0.4 of Probe and 0.4 μL of each primer. The cycling conditions were: 55 °C for 10 min, followed by 95 °C and 40 cycles of 95 °C for 60 s, 60 °C for 30 s.

Statistical analysis

The relative abundance of different mosquito species was calculated per locality. The distribution and abundance of Ae. aegypti in the study area were assessed using the ovitrap positive index (OPI; number of ovitraps containing Aedes eggs/number of traps examined × 100) and egg density index (EDI; average number of Aedes eggs per ovitrap). The anthropophilic rate (AR; number of mosquitoes that fed on human blood/ number of all fed mosquitoes x100), outdoor biting rate (OBR; number of mosquitoes collected host-seeking outdoor/ total number of mosquitoes collected host-seeking x 100) and endophilic rate (ER; number of mosquitoes collected by resting indoor/ total number of mosquitoes collected by aspiration x 100) were calculated for Ae. aegypti for each site. The effect of sampling sites on the species richness and EDI of Ae. aegypti was analyzed using a generalized linear mixed-effect model, using sampling periods as random factors, with Poisson error distribution. Tukey’s honestly significant difference (HSD) post hoc test was used to identify significant pairwise comparisons.

Categorical variables (OPI, OBR, AR, and ER) of all sites were first compared using Chi-square or Fisher exact test when appropriate. When the test was statistically significant, sites with the lowest values were progressively removed until the remaining become comparable.

Mosquito susceptibility to insecticides was interpreted according to WHO guidelines [32]. Mortality rates between 98–100% indicated susceptibility, mortality rates from 90 to 97% indicated possible resistance and mortality rates less than 90% indicated confirmed resistance. The Abbott formula was applied for mortality correction when necessary [32].

Knockdown times (KDT50 and KDT95) were calculated using the Probit model with a 95% confidence interval using the BioRssay package [36]. Kdr genotype frequencies were compared between phenotypically resistant (alive) and susceptible (dead) mosquitoes using Pearson’s chi-square test or Fisher’s exact test, depending on sample size. All tests were considered statistically significant when p < 0.05. Data were analyzed using R statistical software, version 4.3.1 [37].

Results

Spatio‑temporal distribution of Aedes species eggs during the study period

A total of 282,534 Aedes eggs were collected during the study period, with an average of 39.12 eggs per ovitrap per week. The number of eggs per ovitrap ranged from 0 to 1,497. Aedes eggs were recorded in all sites throughout most of the sampling period.

The highest EDI were observed between August to October (epidemiological weeks 34–43) in all study sites (Fig 2). Thereafter, egg density gradually declined over the following weeks.

Fig 2. Spatial distribution and frequency of Aedes eggs collected in Dakar during the surveillance period, july-2022 to August 2023.

Fig 2

A significant variation in the OPI was observed across the different neighborhoods (Table 1; χ2 = 486.44, df = 14, p-value < 2.2e-16). The highest and statistically comparable OPI were recorded in Sicap Liberté (59.8), Point E (58.04) and Mbao (57.84), whereas the lowest values were observed in Pikine, Guédiawaye and Keur Massar.

Table 1. Ovitrap indices in 15 localities of Dakar from July 2022 to August 2023.

Sites Ovitraps placed Positive ovitraps Ovitrap positive index (OPI) Egg Numbers Egg density index (EDI)
Grand Dakar 510 175 34.31 15492 16.86 [10.84-26.2]
Grand Yoff 500 209 41.80 23974 27.20 [17.49-42.3]
Guédiawaye 510 130 25.49 6237 6.78 [4.36-10.6]
Hann Village 460 203 44.13 20212 22.52 [14.48-35.0]
Keur Massar 469 109 23.24 9777 11.01 [7.08 -17.1] **
Mbao 510 295 57.84* 28251 30.72 [19.76 -47.8]
Médina 520 174 33.46 9715 10.52 [6.76-16.4] **
Ngor 420 136 32.38 14891 18.00 [11.58-28.0] *
Ouakam 489 208 42.54 19324 21.53 [13.85-33.5]
Parcelles 510 150 29.41 11539 12.55 [8.07-19.5]
Pikine 350 93 26.57 12569 15.85 [2.47-3.06]
Plateau 490 200 40.82 25505 28.68 [18.45-44.6]
Point E 510 296 58.04* 38720 42.31 [27.22-65.8]
Sicap Liberté 490 293 59.80* 30252 34.09 [21.93- 53.0]
Yoff 508 191 37.60 16076 17.76 [11.42-27.6]*

(*) Stars indicate that the EDI and the OPI values for these sites are not significantly different.

The EDI of Ae. aegypti was similar only between Keur Massar and Medina (p = 0.09), and between Ngor and Yoff (p = 0.99). All other pairwise comparisons showed statistically significant differences (p < 0.001).

Adult mosquito species abundance

A total of 34,666 mosquitoes belonging to four genera (Aedes, Culex, Mansonia and Anopheles) and 16 species were collected. Species richness varied across the surveyed localities, ranging from 3 species in Ouakam to 15 species in Mbao (S1 Table). Mbao exhibited the significantly highest mean species richness (Mean = 6.31; 95% CI: 4.26–9.34) compared to the other localities (p < 0.05). The other localities showed lower and comparable mean species richness (S2 Table). The most abundant species were: Cx. quinquefasciatus (n = 30,121; 86.9% of the mosquito fauna), Ae. aegypti (n = 1959; 5.65%), Ma. africana (n = 1037; 3.0%), Cx. tritaeniorhynchus (n = 712; 2.0%), Ma. uniformus (n = 435; 1.25%) and An. gambiae s.l. (n = 298; 0.8%). Each of the other species (An. pharoensis, An. sp, An. rufipes, Cx. theileri, Cx. cinereus, Cx. antennatus, Cx. neavei, Cx. nebulosus, Cx. perfuscus, Cx. poicilipes) represented less than 0.5% of the total collection.

Aedes aegypti adult mosquito abundance

Aedes aegypti was the only species of the Aedes genus collected, and its presence was recorded at all study sites (Table 2). The relative abundances of this species across sites showed a statistically significant difference (χ2 = 10.86, df = 3, p = 0.01). The proportions observed in Grand Yoff (7.50%), Guédiawaye (1.04%), Mbao (1.21%) and Ouakam (4.45%) were statistically comparable (χ2 = 5.19, df = 3, p = 0.16) and consistently lower than those in Point E (36.11%) and Médina (19.83%).

Table 2. Number of adult Aedes aegypti collected from August 2022 to July 2023 in Dakar.

Aspiration BG Lure + CO2 Total
Indoor Outdoor Indoor Outdoor
Localities Total Day Night Day Night Total
Grand Yoff 38 73 111 5 15 6 26 137
Guédiawaye 21 45 66 16 12 26 10 64 130
Mbao 27 86 113 6 2 18 23 49 162
Médina 34 151 185 45 15 47 29 136 321
Ouakam 12 10 22 4 5 50 30 89 111
Point E 151 201 352 270 125 186 165 746 1098
Total 283 566 849 346 159 342 263 1110 1959

In all neighborhoods the highest densities of Ae. aegypti adults were recorded from August to November, corresponding to the rainy season (Fig 3). Overall vector abundance peaked in September, then declined gradually, reaching very low levels between December and June.

Fig 3. Mean number of host-seeking Aedes aegypti females collected using Biogents (BG) Sentinel traps in Dakar from August 2022 to July 2023.

Fig 3

Error bars indicate 95% CI: 95% Confidence interval.

Resting and biting patterns

Ae. aegypti females were primarily collected outdoors in three localities (Grand Yoff, Mbao and Ouakam), while in the other localities, they were collected both indoors and outdoors. The OBR varied significantly across the six sites (p = 0.0004). The OBR of Mbao, Grand Yoff and Ouakam were higher and comparable (p = 0.08). Host-seeking activity was mainly diurnal, with 68.5% of the females collected indoors during the daytime and 56.5% outdoors during the daytime. A higher proportion of female Ae. aegypti was found resting indoors in only one of the six investigated neighborhoods (Fig 4). The ER of Ae. aegypti varied significantly across the six sites (p = 0.04). The ER at Point E was higher than the five others, which were comparable (p = 0.16).

Fig 4. Indoor and outdoor host seeking and resting behavior of adult female Aedes aegypti collected in in six localitiesin Dakar from August 2022 to July2023.

Fig 4

For each variable, localities with different letters are significantly differents.

Host preferences of adult Aedes aegypti

The tested females exhibited a strong Anthropophilic rate, which accounted for 75% of the identified blood meals (105 of 140) (Fig 5). The AR varied significantly across sites (p = 0.0008). The AR at Médina was lower than the other sites wish were comparable (p = 0.7). Other hosts detected included cattle, horses and sheep.

Fig 5. Blood feeding patterns of Aedes aegypti collected in six neighborhoods of Dakar, August 2022 to July 2023.

Fig 5

Anthropophilic rates with different letters are significantly different.

Virus detection and serotyping

Virus detection assays were conducted on 1959 (616 pools) Ae. aegypti mosquitoes, including 874 females (395 pools) and 1,085 males (221 pools) (Table 3) and combined into super pools.

Table 3. Aedes aegypti mosquitoes positive for arboviruses in Dakar, August-2022 to July 2023.

Sites Number of Mosquitos Pools positive Flaviviruses Month of collection Serotype
Grand Yoff 137 1 November
Guédiawaye 130 1 September Dengue-3
Mbao 162 1 November
Médina 321 0
Point E 1098 1 December Dengue-3
Ouakam 111 0
Total 1959 4

Overall, four pools were positive for Flaviviruses by qRT-PCR (Table 3). No pool was positive for Alphaviruses. All positive pools were blood-fed females that were collected in September (Guédiawaye, 1 pool), November (Grand Yoff and Mbao, 1 pool each) and December 2022 (Point E, 1 pool). Of these, only two samples were successfully serotyped as DENV-3. The sequences obtained in this study were analyzed alongside a subset of DENV whole genomes from various serotypes and genotypes available in GenBank. Phylogenetic analysis revealed that the detected DENV-3 strain belongs to the genotype III clade (MP621_Senegal = PV834968; MP638_Senegal = PV834969). These sequences clustered in a distinct clade, forming a monophyletic group with strains previously reported in Senegal (2018), Burkina Faso (2017) and Benin (2023) (Fig 6).

Fig 6. Phylogenetic relationships between newly generated DENV whole-genome sequences from Dakar (collected between August 2022 to July 2023) and reference sequences representing various serotypes and genotypes retrieved from GenBank, including previously reported West African genotypes.

Fig 6

Insecticide susceptibility status of Aedes aegypti populations

Results of insecticide susceptibility tests on Ae. aegypti populations collected from six neighborhoods in the Dakar region are presented in Fig 7. In all tests, no mortality was observed in the control groups.

Fig 7. Insecticide susceptibility status of Aedes aegypti populations collected from six localities in Dakar from August 2022 to July 2023.

Fig 7

This map was created using the R software (version 4.4.0) and the package raster using an empty shapefile from the HDX website (https://data.humdata.org/dataset/senegal-administrative-boundaries) available under Creative Commons Attribution 4.0 International licence.

All tested Ae. aegypti populations showed high resistance to diagnostic doses of pyrethroids, with mortality rates ranging from 35.35% to 64.63%. Most of these populations also exhibited resistance to Anopheles intensity doses. Suspected resistance was noted with 0.25% deltamethrin in 3 localities (Ouakam: 93%, Point E:92.55% and Mbao: 92.10%), 0.25% lambda-cyhalothrin in 2 localities (Guédiawaye: 94.68% and Mbao: 92.38%), and 0.25% alpha-cypermethrin in 2 localities (Mbao: 97% and Guédiawaye: 90.62%). Only the population of Ouakam showed sensitivity to 0.25% lambda-cyhalothrin (97.84%), while Ae. aegypti populations from Point E (94.68%) showed moderate resistance to 3.75% permethrin (94.68%). In other localities, mosquitoes were susceptible.

The same observation was made for the organophosphates, where all mosquito populations exhibited complete resistance, except for those in Guédiawaye (90%) and Point E (96%), which showed suspected resistance to malathion and pirimiphos-methyl, respectively.

The Knockdown times (KDT50 and KDT95) values at diagnostic doses were considerably higher compared to those observed at higher-intensity pyrethroids doses in all Ae. aegypti populations tested (S3 Table), indicating a strong level of phenotypic resistance. At standard diagnostic doses, mosquitoes required more time to be knocked down, values frequently exceeding one hour (Fig 8).

Fig 8. Knockdown rates of Aedes aegypti from six localities in Dakar following exposure to pyrethroids from August 2022 to July 2023.

Fig 8

KD = Knockdown, Diagnostic dose = 0.4% permethrin, 0.03% deltamethrin, 0.08% lambda-cyhalothrin, 0.08% alpha-cypermethrin, Intensity dose = 3.75% permethrin, 0.25% deltamethrin, 0.25% lambda-cyhalothrin, 0.25% alpha-cypermethrin.

Genotyping of kdr resistant mutations and their association with phenotypic resistance

Genomic DNA of 1,014 individual mosquitoes, including alive and dead specimens exposed to pyrethroids, was obtained from six neighborhoods. Assays were then performed to detect the S989P, V1016G/I and F1534C mutations. The genotypes and allele frequencies of each kdr mutation are shown in Table 4 and S4 Table.

Table 4. Number of genotypes and frequencies of kdr mutations in the VGSC gene of Aedes aegypti from six localities in Dakar.

Phenotype Kdr F1534C Allele Freq Kdr V1016I Allele Freq Kdr V1016G Allele Freq Kdr S989P Allele Freq
Sites CC FC FF p-value II VI VV GG VG VV p-value PP SP SS p-value
F(C) F(I) F(G) F(P)
Médina Alive 0 40 54 0.21 0.8852 0 0 94 0 81 13 0.43 0.6638 3 83 8 0.47 0.477
Dead 0 44 56 0.22 0 0 100 0 89 11 0.44 7 84 9 0.47
PE Alive 2 52 44 0.28 0.08164 0 0 99 0 95 4 0.47 0.6918 1 51 46 0.27 0.3247
Dead 0 34 48 0.20 0 0 81 0 79 2 0.48 0 50 32 0.30
Mbao Alive 0 60 19 0.37 0.2093 0 0 79 0 79 0 0.50 1 0 79 0 0.50 1
Dead 2 57 12 0.42 0 0 71 0 71 0 0.50 0 71 0 0.50
Ouakam Alive 1 7 69 0.02 0.4729 0 0 77 0 77 0 0.50 1 0 77 0 0.50 1
Dead 0 6 84 0.08 0 0 90 0 90 0 0.50 0 90 0 0.50
Grand Yoff Alive 0 36 63 0.18 0.06558 0 0 99 0 99 0 0.50 1 0 99 0 0.50 1
Dead 1 17 55 0.13 0 0 73 0 73 0 0.50 0 73 0 0.50
Guédiawaye Alive 0 0 85 1 0 0 85 0 79 6 0.46 0.004232 1 84 0 0.50 4.816e-12
Dead 0 0 62 0 0 62 0 47 15 0.37 2 36 24 0.32

CC, II, VV, and SS = homozygous wild-type; FC, VI, VG, and SP = heterozygous (mutant/wild-type); FF, II, GG, and PP = homozygous mutant. Freq = frequency of the mutant allele.

Only two homozygous mutation types were observed in the tested samples: 1534C and 989P. The 1534C mutation was detected at all sites except Médina and Guédiawaye in both resistant (allelic frequencies: 0 to 0.50) and susceptible groups (allelic frequencies: 0 to 0.54). The allele frequency for the 989P mutation ranged from 0 to 0.52 in the resistant group and 0 to 0.53 in the susceptible group in the localities of Médina, Point E and Guédiawaye. The predominant genotype was the heterozygous mutant for the F1534C, S989P and V1016G mutations. The V1016I mutation was not detected. In the main analysis, no significant association was observed between kdr mutations and mosquito phenotype (alive or dead), except in Guédiawaye, where the frequencies of S989P and V1016G were significantly higher in the resistant group (Table 4).

Thirteen genotypes were observed across the four kdr loci in the 1,014 mosquitoes genotyped (Fig 9). The most common four-locus genotype detected across all sites were the heterozygous mutants for F1534C (FC), S989P (SP) and V1016G (VG) combined with the homozygous susceptible type for V1016I (VV). This four-locus genotype (FF/VV/VG/SP) was found in 295 (29.20%) resistant and 277 (27.42%) susceptible specimens. The four-homozygous mutant FC/VV/VG/SP was present in 159 (15.74%) resistant and 135 (13.36%) susceptible specimens (Fig 9). Multi-locus genotypes combining these mutations were detected at comparable frequencies in both resistant and susceptible mosquitoes in all localities (p > 0,05).

Fig 9. Frequencies of four‑locus genotypes for the voltage-gated sodium channel (VGSC) kdr mutations in phenotyped Aedes aegypti.

Fig 9

Each four‑locus genotype is represented in the order of F1534C/ V1016G/ S989P. Genotypes are indicated as follows: F1534C – FF: wild type (susceptible), FC: heterozygote, CC: mutant (resistant); V1016G – VV: wild type (susceptible), VG: heterozygote; S989P – SS: wild type (susceptible), SP: heterozygote, PP: mutant (resistant). Freq indicates the frequency of each multilocus genotype in the tested mosquito population.

Discussion

Long-term vector surveillance is crucial for developing effective strategies to prevent and control dengue transmission. This study provides valuable information on the spatiotemporal distribution and population density of Aedes vectors, based on egg and adult collections, as well as evidence of insecticide resistance and associated kdr mutations. It represents the first longitudinal assessment of Ae. aegypti populations in Dakar, the capital of Senegal.

Our findings indicate that, Ae. aegypti eggs were present in high numbers across all study areas during most of the sampling periods. The use of ovitraps allowed for the identification of varying infestation levels and seasonal fluctuations in vector populations [38]. The detection of eggs confirms the presence of gravid females having actively fed on vertebrate hosts, underscoring the risk of arbovirus transmission. Thus, ovitraps play a key role in enhancing vector surveillance and enabling early detection of vector presence [3941]. In this study, ovitraps were used as a sensitive monitoring tool to detect Aedes presence and estimate population density. It was observed that, the proportion of Aedes eggs was significantly higher in Mbao, Point E, and Sicap Liberté compared to other areas. Notably, the highest egg density was recorded in September (rainy season), coinciding with the peak period of DENV-positive mosquito detections (August-December: rainy season). These localities and periods should be prioritized for vector control operations. The use of ovitraps have been shown in other contexts to potentially reduce vector populations highlighting their sensitivity as a vector control tools [42,43]. Although beyond the scope of this study, the evaluation of their impact on mosquito control should be explored in our context.

This study also revealed variations in species richness and abundance across the sites. Higher species diversity was observed in Mbao, a site near a classified forest, whereas lower species diversity and higher mosquito abundance were found in the two most urbanized localities (Point E and Médina). This is in accordance with a previous study that suggested that human-induced environmental changes tend to favor mosquito abundance while reducing species diversity, whereas natural environments typically support higher species diversity but lower abundance [44].

Blood meal analysis indicated that, Ae. aegypti predominantly fed on humans in most areas except Médina, indicating a high risk of arbovirus transmission [45]. We observed highly anthropophilic behavior in Ae. aegypti, the main vector of DENV was consistent with the results of previous studies conducted in Senegal [1,46]. However, the host diversity that we observed in Médina suggests that this species may exhibit opportunistic feeding behavior, depending on host availability. We acknowledge that the anthropophilic rate in Médina was unexpectedly low compared to the other sites. Although we did not conduct specific surveys to quantify the number of domestic animals in each locality, sociocultural differences may explain the observed variation. Future studies incorporating animal census data and finer-scale environmental variables would help clarify these patterns.

Furthermore, differences in resting and biting patterns of Ae. aegypti were observed across the six sampling sites. In Grand Yoff, Mbao, and Ouakam, females were primarily collected outdoors, suggesting more intense host-seeking activity in peri-domestic environments. In contrast, in Médina, Point E, and Guédiawaye, mosquitoes were collected both indoors and outdoors, indicating more flexible host-seeking. Host-seeking activity was predominantly diurnal in all sites, with 68.5% of females collected indoors and 56.5% outdoors during daytime, in agreement with findings from previous studies [46]. This suggested that mosquito control operations should be done mainly outdoor during the day. The Endophilic Rate (ER) also varied significantly among sites, with the highest value recorded at Point E. These spatial variations in behavioral patterns may be influenced by ecological and socio-environmental factors, such as housing type, human activity, or vector control practices, and underscore the need for locally tailored intervention strategies.

Flavivirus was detected in four of the 6 neighborhoods where adult mosquitoes were collected and tested (Grand Yoff, Guédiawaye, Mbao, and Point E). The detection of virus-positive pools in multiple, geographically dispersed sites indicates a possibly widespread viral circulation in the urban environment, highlighting the risk of human transmission across Dakar. Consequently, implementing regular control strategies to minimize human/vector contact is highly recommended for limiting arbovirus transmission in the Dakar area. Phylogenetic analysis of DENV-3 strains isolated during monitoring revealed their classification within genotype III. The serotype 3 detected in this study was responsible for the first dengue outbreak recorded in Dakar in 2009 [47] and is currently the most frequency associate outbreaks in Senegal [48]. The high risk of transmission in Senegal may be due to the geographical proximity to Benin and Burkina Faso, coupled with significant human migratory flows. Additionally, rapid urbanization has been identified as a key factor facilitating dengue transmission [49]. Attempts to sequence the viral RNA from the two other pools were unsuccessful, probably due to low RNA quality or quantity. Mosquito-based viral surveillance is a fundamental component of arbovirus control, as it helps in detecting and monitoring local viral activity, assessing endemicity levels, and identifying high-risk areas [50].

Assessing the susceptibility of Ae. aegypti to different insecticides under laboratory conditions is an important indicator for evaluating the effectiveness of insecticides-based control strategies. In this study, all tested Ae. aegypti populations showed resistance to pyrethroids when assessed using the new diagnostic doses recommended by the WHO for Aedes mosquitoes, despite a high knockdown rate. Some populations also exhibited suspected resistance at intensity doses (5 or 10 times higher than diagnostic doses). The presence of pyrethroid resistance in Ae. aegypti had previously been demonstrated in Senegal using diagnostic doses developed for Anopheles [7]. The widespread resistance observed in Ae. aegypti populations in Dakar to all insecticides tested including carbamates, organophosphates, and organochlorines may be explained by multiple sources of insecticide exposure. With the contact man-vector, insecticides are commonly used in households for nuisance mosquito control. In particular, pyrethroids such as permethrin, deltamethrin, and allethrin are widely used in Dakar households for nuisance mosquito control in the form of sprays, coils, and aerosols [6]. Carbamates such as propoxur are used in reactive intervention campaigns during epidemics, and resistance to this class of insecticides (bendiocarb) has been observed [7]. Additionally, among our six sites, Guédiawaye and Mbao are part of the Niayes zone. This area is, characterized by intensive urban agriculture, particularly market gardening, which involves frequent use of organophosphates and pyrethroids [51]. Ae. aegypti is characterized by a limited flight range, generally not exceeding 100–200 meters under natural conditions [52], although some individuals have been reported to travel up to 800 meters [53]. This could contribute to a constant environmental pressure selecting for resistant individuals. Similar patterns have been observed in Ghana, where extensive use of agricultural insecticides has been linked to increased resistance levels in mosquito populations [54,55]. Although pyrethroid-treated bed nets and IRS are primarily aimed at malaria vectors, their widespread and long-term use in Senegal may also exert indirect selection pressure on Ae. aegypti populations exposed to these interventions in peri-domestic environments [56]. Given these findings, regular monitoring of insecticide resistance in Ae. aegypti populations is essential to inform vector control strategies. It allows timely adjustments in the choice of insecticides, the rotation of active ingredients to manage resistance, and the adoption of complementary measures such as larvicide or the introduction of Wolbachia infected mosquitoes. This evidence-based approach helps optimize public health interventions and maintain the effectiveness of vector control programs.

This study also provides the first documented evidence of kdr mutations in Ae. aegypti populations in Senegal. Specifically, the homozygous resistant of 1534C and 989P mutations (specifically CC an PP) and the heterozygote resistant of 1016G (VG) were detected at in both resistant and susceptible populations. Except for the V1016G and S989P mutations in Guédiawaye, no significant differences in Ae. aegypti allele frequencies were observed between resistant and susceptible mosquitoes despite the resistance to pyrethroids. A prior study conducted in Senegal in 2019 reported a complete absence of kdr mutations [7]. The recent detection of kdr mutations in Ae. aegypti populations in Senegal, including S989P, V1016G, and F1534C, suggests a possible emergence or introduction of resistance alleles that may expand over time. This pattern is similar to studies from Burkina Faso, where the V1016I mutation was first reported at moderate frequencies and progressively increased over the years [57]. The potential for a rapid increase of resistance alleles once they emerge in a population, particularly under continuous insecticide pressure, is highlighted by this trend. Monitoring these dynamics is therefore critical for anticipating resistance spread and adapting vector control strategies accordingly [58]. In addition, previous studies conducted in Senegal concluded that metabolic resistance by detoxifying enzymes is the main mechanism leading to pyrethroid resistance in Ae. aegypti. In particular, high expression levels of cytochrome P450 genes such as CYP9J26, CYP9J28, CYP9J32, CYP6BB2, CYP9J32 and CYP9J26 were noted. A significant overexpression of the glutathione S-transferase gene GSTD4 and the esterase gene CCEae3a was observed on all tested Ae. aegypti in Senegal [7]. Several multi-locus genotypes combining these mutations were detected at comparable frequencies in both resistant and susceptible mosquitoes. These findings highlight the complexity of resistance in Senegal and support the need for comprehensive surveillance integrating both target-site and metabolic mechanisms. Although the triple mutant homozygote (S989P + V1016G + F1534C) has not yet been detected in Senegal, its potential emergence remains a concern, as Hirata et al. (2014) [59] demonstrated that this combination can significantly increase pyrethroid resistance and potentially compromise vector control strategies.

This suggests that their involvement in pyrethroid resistance cannot be confirmed. One limitation of this study is that the V410L kdr mutation, which has been increasingly reported in Ae. aegypti populations across West Africa, was not included in our screening panel [11,14,15]. Given its potential role in pyrethroid resistance, future investigations should consider incorporating the V410L mutation in molecular monitoring efforts in Senegal.

Conclusion

Our results demonstrate that the implementation of a monitoring system using ovitraps is both sensitive and efficient, requiring minimal resources for routine inclusion in dengue control programs. Moreover, a limited number sites is sufficient, as no significant differences were observed in the temporal dynamics of eggs among neighborhoods.

Our results also provide the first data on the distribution, breeding sites, blood-feeding behavior, biting patterns, and resting site preferences for adult Ae. aegypti in Dakar. Our findings indicate that, Ae. aegypti is well-established in Dakar. The effectiveness of vector control measures may be compromised by the exophagic and diurnal behavior of this species.

The detection of kdr mutations F1534C, V1016G, V1016I, S989P, along with the overexpression of several detoxification genes is alarming. It is important to assess the intensity of resistance and explore complementary control strategies (such as Bacillus thuringiensis var. israelensis (Bti), Wolbachia infection, sterile insect techniques and genetic manipulation, particularly in African countries where dengue epidemics can have severe health impacts.

Supporting information

S1 Table. Number of adult mosquitoes collected from August 2022 to July 2023 in Dakar.

(DOCX)

pntd.0013657.s001.docx (20.1KB, docx)
S2 Table. Mean number of mosquitoes species collected per localities per month in Dakar from August 2022-July2023.

(DOCX)

pntd.0013657.s002.docx (13.3KB, docx)
S3 Table. Knockdown times (KDT₅₀ and KDT₉₅, with 95% confidence intervals) of Aedes aegypti following exposure to different concentrations of pyrethroids across six localities in Dakar/ August 2022 to July 2023.

(DOCX)

pntd.0013657.s003.docx (17.3KB, docx)
S4 Table. Number of genotypes and frequencies of kdr mutations in the VGSC gene of Aedes aegypti from six localities in Dakar.

(DOCX)

pntd.0013657.s004.docx (29.5KB, docx)

Acknowledgments

We thank all the study participants, the field workers and the lab technicians, PhD Research Associate in Institut Pasteur de Dakar. Authors’ Disclaimer Statement: The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the U.S. Department of the Navy, U.S. Department of Defense, nor the U.S. Government. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Navy. Copyright Assignment statement: CDR Harwood and Dr. Nimo-Paintsil are military service members or employees of the U.S. Government. This work was prepared as part of their official duties. Title 17 U.S.C. §105 provides that ‘Copyright protection under this title is not available for any work of the United States Government.’ Title 17 U.S.C. §101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person’s official duties.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was supported by Armed Forces Health Surveillance Division, Global Emerging Infections Surveillance (AFHSD/GEIS) Branch; (PROMIS numbers P0041_22_N3, P0036_23_N3 to James F. Harwood) and the West African Center for Emerging Infectious Diseases (NIH/NIAID) (U01AI151801 to Scott C. Weaver). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Diouf B, Sene NM, Ndiaye EH, Gaye A, Ngom EHM, Gueye A, et al. Resting behavior of blood-fed females and host feeding preferences of Aedes aegypti (Diptera: Culicidae) morphological forms in Senegal. J Med Entomol. 2021;58(6):2467–73. doi: 10.1093/jme/tjab111 [DOI] [PubMed] [Google Scholar]
  • 2.Diallo D, Diouf B, Gaye A, Ndiaye EH, Sene NM, Dia I, et al. Dengue vectors in Africa: a review. Heliyon. 2022;8(5):e09459. doi: 10.1016/j.heliyon.2022.e09459 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Dieng I, Cunha M, Diagne MM, Sembène PM, Zanotto PM de A, Faye O, et al. Origin and spread of the dengue virus type 1, genotype V in Senegal, 2015-2019. Viruses. 2021;13(1):57. doi: 10.3390/v13010057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Dieng I, Barry MA, Talla C, Sow B, Faye O, Diagne MM, et al. Analysis of a Dengue virus outbreak in Rosso, Senegal 2021. Trop Med Infect Dis. 2022;7(12):420. doi: 10.3390/tropicalmed7120420 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Guo C, Zhou Z, Wen Z, Liu Y, Zeng C, Xiao D, et al. Global epidemiology of dengue outbreaks in 1990-2015: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2017;7:317. doi: 10.3389/fcimb.2017.00317 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Dia I, Diagne CT, Ba Y, Diallo D, Konate L, Diallo M. Insecticide susceptibility of Aedes aegypti populations from Senegal and Cape Verde Archipelago. Parasit Vectors. 2012;5:238. doi: 10.1186/1756-3305-5-238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Sene NM, Mavridis K, Ndiaye EH, Diagne CT, Gaye A, Ngom EHM, et al. Insecticide resistance status and mechanisms in Aedes aegypti populations from Senegal. PLoS Negl Trop Dis. 2021;15(5):e0009393. doi: 10.1371/journal.pntd.0009393 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Yougang AP, Keumeni CR, Wilson-Bahun TA, Tedjou AN, Njiokou F, Wondji C, et al. Spatial distribution and insecticide resistance profile of Aedes aegypti and Aedes albopictus in Douala, the most important city of Cameroon. PLoS One. 2022;17(12):e0278779. doi: 10.1371/journal.pone.0278779 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kamgang B, Acântara J, Tedjou A, Keumeni C, Yougang A, Ancia A, et al. Entomological surveys and insecticide susceptibility profile ofAedes aegyptiduring the dengue outbreak in Sao Tome and Principe in 2022. Cold Spring Harbor Laboratory; 2024. doi: 10.1101/2024.01.07.574582 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Marcombe S, Fustec B, Cattel J, Chonephetsarath S, Thammavong P, Phommavanh N, et al. Distribution of insecticide resistance and mechanisms involved in the arbovirus vector Aedes aegypti in Laos and implication for vector control. PLoS Negl Trop Dis. 2019;13(12):e0007852. doi: 10.1371/journal.pntd.0007852 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ayres CFJ, Seixas G, Borrego S, Marques C, Monteiro I, Marques CS, et al. The V410L knockdown resistance mutation occurs in island and continental populations of Aedes aegypti in West and Central Africa. PLoS Negl Trop Dis. 2020;14(5):e0008216. doi: 10.1371/journal.pntd.0008216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Konan LY, Oumbouke WA, Silué UG, Coulibaly IZ, Ziogba J-CT, N’Guessan RK, et al. Insecticide resistance patterns and mechanisms in Aedes aegypti (Diptera: Culicidae) populations across Abidjan, Côte d’Ivoire Reveal Emergent Pyrethroid Resistance. J Med Entomol 2021;58(4):1808–16. doi: 10.1093/jme/tjab045 [DOI] [PubMed] [Google Scholar]
  • 13.Ould Lemrabott MA, Briolant S, Gomez N, Basco L, Ould Mohamed Salem Boukhary A. First report of kdr mutations in the voltage-gated sodium channel gene in the arbovirus vector, Aedes aegypti, from Nouakchott, Mauritania. Parasit Vectors. 2023;16(1):464. doi: 10.1186/s13071-023-06066-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sombié A, Ouédraogo WM, Oté M, Saiki E, Sakurai T, Yaméogo F, et al. Association of 410L, 1016I and 1534C kdr mutations with pyrethroid resistance in Aedes aegypti from Ouagadougou, Burkina Faso, and development of a one-step multiplex PCR method for the simultaneous detection of 1534C and 1016I kdr mutations. Parasit Vectors. 2023;16(1):137. doi: 10.1186/s13071-023-05743-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Maiga A-A, Sombié A, Zanré N, Yaméogo F, Iro S, Testa J, et al. First report of V1016I, F1534C and V410L kdr mutations associated with pyrethroid resistance in Aedes aegypti populations from Niamey, Niger. PLoS One. 2024;19(5):e0304550. doi: 10.1371/journal.pone.0304550 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Tokponnon TF, Ossè R, Zoulkifilou SD, Amos G, Festus H, Idayath G, et al. Insecticide resistance in Aedes aegypti mosquitoes: possible detection of kdr F1534C, S989P, and V1016G triple mutation in Benin, West Africa. Insects. 2024;15(4):295. doi: 10.3390/insects15040295 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Smith LB, Kasai S, Scott JG. Pyrethroid resistance in Aedes aegypti and Aedes albopictus: important mosquito vectors of human diseases. Pestic Biochem Physiol. 2016;133:1–12. doi: 10.1016/j.pestbp.2016.03.005 [DOI] [PubMed] [Google Scholar]
  • 18.Dusfour I, Vontas J, David J-P, Weetman D, Fonseca DM, Corbel V, et al. Management of insecticide resistance in the major Aedes vectors of arboviruses: advances and challenges. PLoS Negl Trop Dis. 2019;13(10):e0007615. doi: 10.1371/journal.pntd.0007615 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Montgomery M, Harwood JF, Yougang AP, Wilson-Bahun TA, Tedjou AN, Keumeni CR, et al. Spatial distribution of insecticide resistant populations of Aedes aegypti and Ae. albopictus and first detection of V410L mutation in Ae. aegypti from Cameroon. Infect Dis Poverty. 2022;11(1):90. doi: 10.1186/s40249-022-01013-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ishak IH, Kamgang B, Ibrahim SS, Riveron JM, Irving H, Wondji CS. Pyrethroid resistance in malaysian populations of dengue vector Aedes aegypti is mediated by CYP9 family of cytochrome P450 genes. PLoS Negl Trop Dis. 2017;11(1):e0005302. doi: 10.1371/journal.pntd.0005302 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Edwards FW. Mosquitoes of the Ethiopian region. III.- Culicine adults and pupae. London: British Museum (Nat Hist); 1941. [Google Scholar]
  • 22.Diagne N, Fontenille D, Konate L, Faye O, Lamizana MT, Legros F, et al. Anopheles of Senegal. An annotated and illustrated list. Bull Soc Pathol Exot. 1994;87(4):267–77. [PubMed] [Google Scholar]
  • 23.Vina-Rodriguez A, Sachse K, Ziegler U, Chaintoutis SC, Keller M, Groschup MH, et al. A novel pan-flavivirus detection and identification assay based on RT-qPCR and microarray. Biomed Res Int. 2017;2017:4248756. doi: 10.1155/2017/4248756 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Faye O, Freire CCM, Iamarino A, Faye O, de Oliveira JVC, Diallo M, et al. Molecular evolution of Zika virus during its emergence in the 20(th) century. PLoS Negl Trop Dis. 2014;8(1):e2636. doi: 10.1371/journal.pntd.0002636 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Twist B. Twist comprehensive viral research panel. Accessed 2024 December 12. https://www.twistbioscience.com/resources/product-sheet/twist-comprehensive-viral-research-panel
  • 26.Dieng I, Sadio BD, Gaye A, Sagne SN, Ndione MHD, Kane M, et al. Genomic characterization of a reemerging Chikungunya outbreak in Kedougou, Southeastern Senegal, 2023. Emerg Microbes Infect. 2024;13(1):2373308. doi: 10.1080/22221751.2024.2373308 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Langelier C, Lu D, Kalantar K, Chu V, Glascock A, Guerrero E, et al. Simultaneous detection of pathogens and antimicrobial resistance genes with the open source, cloud-based, CZ ID pipeline. Res Sq. 2024. doi: 10.21203/rs.3.rs-4271356/v1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Katoh K, Rozewicki J, Yamada KD. MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization. Brief Bioinform. 2019;20(4):1160–6. doi: 10.1093/bib/bbx108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Nguyen L-T, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015;32(1):268–74. doi: 10.1093/molbev/msu300 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lin Y, Hu F, Tang J, Moret BME. Maximum likelihood phylogenetic reconstruction from high-resolution whole-genome data and a tree of 68 eukaryotes. In: Biocomputing 2013, 2012. 285–296. doi: 10.1142/9789814447973_0028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Beier JC, Perkins PV, Wirtz RA, Koros J, Diggs D, Gargan TP 2nd, et al. Bloodmeal identification by direct enzyme-linked immunosorbent assay (ELISA), tested on Anopheles (Diptera: Culicidae) in Kenya. J Med Entomol. 1988;25(1):9–16. doi: 10.1093/jmedent/25.1.9 [DOI] [PubMed] [Google Scholar]
  • 32.World Health Organization. Test procedures for insecticide resistance monitoring in malaria vector mosquitoes. 2nd ed. Geneva: World Health Organization; 2018. [Google Scholar]
  • 33.Morlais I, Ponçon N, Simard F, Cohuet A, Fontenille D. Intraspecific nucleotide variation in Anopheles gambiae: new insights into the biology of malaria vectors. Am J Trop Med Hyg. 2004;71(6):795–802. doi: 10.4269/ajtmh.2004.71.795 [DOI] [PubMed] [Google Scholar]
  • 34.Saavedra-Rodriguez K, Maloof FV, Campbell CL, Garcia-Rejon J, Lenhart A, Penilla P, et al. Parallel evolution of vgsc mutations at domains IS6, IIS6 and IIIS6 in pyrethroid resistant Aedes aegypti from Mexico. Sci Rep. 2018;8(1):6747. doi: 10.1038/s41598-018-25222-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Bariami V, Jones CM, Poupardin R, Vontas J, Ranson H. Gene amplification, ABC transporters and cytochrome P450s: unraveling the molecular basis of pyrethroid resistance in the dengue vector, Aedes aegypti. PLoS Negl Trop Dis. 2012;6(6):e1692. doi: 10.1371/journal.pntd.0001692 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Karunarathne P, Pocquet N, Labbé P, Milesi P. BioRssay: an R package for analyses of bioassays and probit graphs. Parasit Vectors. 2022;15(1):35. doi: 10.1186/s13071-021-05146-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.R Core Team. R: The R project for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2016. [Google Scholar]
  • 38.Akyea-Bobi NE, Akorli J, Opoku M, Akporh SS, Amlalo GK, Osei JHN, et al. Entomological risk assessment for transmission of arboviral diseases by Aedes mosquitoes in a domestic and forest site in Accra, Ghana. PLoS One. 2023;18(12):e0295390. doi: 10.1371/journal.pone.0295390 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Cheng ML, Ho BC, Bartnett RE, Goodwin N. Role of a modified ovitrap in the control of Aedes aegypti in Houston, Texas, USA. Bull World Health Organ. 1982;60(2):291–6. [PMC free article] [PubMed] [Google Scholar]
  • 40.Gama RA, Silva EM, Silva IM, Resende MC, Eiras AE. Evaluation of the sticky MosquiTRAP for detecting Aedes (Stegomyia) aegypti (L.) (Diptera: Culicidae) during the dry season in Belo Horizonte, Minas Gerais, Brazil. Neotrop Entomol. 2007;36(2):294–302. doi: 10.1590/s1519-566x2007000200018 [DOI] [PubMed] [Google Scholar]
  • 41.Marten GG. Using ovitraps to assess the quantity of mosquito larval habitat during local eradication with source reduction and ovitraps. J Med Entomol. 2012;49(3):640–6. doi: 10.1603/me10284 [DOI] [PubMed] [Google Scholar]
  • 42.Nascimento KLC, da Silva JFM, Zequi JAC, Lopes J. Comparison between larval survey index and positive ovitrap index in the evaluation of populations of Aedes (Stegomyia) aegypti (Linnaeus, 1762) North of Paraná, Brazil. Environ Health Insights. 2020;14:1178630219886570. doi: 10.1177/1178630219886570 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Chaves LF, Friberg MD. Aedes albopictus and Aedes flavopictus (Diptera: Culicidae) pre-imaginal abundance patterns are associated with different environmental factors along an altitudinal gradient. Curr Res Insect Sci. 2020;1:100001. doi: 10.1016/j.cris.2020.100001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Zahouli JBZ, Utzinger J, Adja MA, Müller P, Malone D, Tano Y, et al. Oviposition ecology and species composition of Aedes spp. and Aedes aegypti dynamics in variously urbanized settings in arbovirus foci in southeastern Côte d’Ivoire. Parasit Vectors. 2016;9(1):523. doi: 10.1186/s13071-016-1778-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Harrington LC, Edman JD, Scott TW. Why do female Aedes aegypti (Diptera: Culicidae) feed preferentially and frequently on human blood?. J Med Entomol. 2001;38(3):411–22. doi: 10.1603/0022-2585-38.3.411 [DOI] [PubMed] [Google Scholar]
  • 46.Sene NM, Diouf B, Gaye A, Ndiaye EH, Ngom EM, Gueye, et al. Blood feeding patterns of Aedes aegypti populations in Senegal. Am J Trop Med Hyg. 2022;106: 1402–5. doi: 10.4269/ajtmh.21-0508 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Faye O, Ba Y, Faye O, Talla C, Diallo D, Chen R, et al. Urban epidemic of dengue virus serotype 3 infection, Senegal, 2009. Emerg Infect Dis. 2014;20(3):456–9. doi: 10.3201/eid2003.121885 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Dieng I, Balde D, Talla C, Camara D, Barry MA, Sagne SN, et al. Molecular evolution of dengue virus 3 in Senegal between 2009 and 2022: dispersal patterns and implications for prevention and therapeutic countermeasures. Vaccines (Basel). 2023;11(10):1537. doi: 10.3390/vaccines11101537 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Were F. The dengue situation in Africa. Paediatr Int Child Health. 2012;32 Suppl 1(s1):18–21. doi: 10.1179/2046904712Z.00000000048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Nealon J, Bouckenooghe A, Cortes M, Coudeville L, Frago C, Macina D, et al. Dengue endemicity, force of infection, and variation in transmission intensity in 13 endemic countries. J Infect Dis. 2022;225(1):75–83. doi: 10.1093/infdis/jiaa132 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Diatte M, Labou B, Sylla S, Tendeng E, Ndiaye IA, Sène SO, et al. Phytosanitary practices in the market garden area of Niayes, Senegal. Acta Hortic. 2022;(1355):179–86. doi: 10.17660/actahortic.2022.1355.23 [DOI] [Google Scholar]
  • 52.Moore TC, Brown HE. Estimating Aedes aegypti (Diptera: Culicidae) flight distance: meta-data analysis. J Med Entomol. 2022;59(4):1164–70. doi: 10.1093/jme/tjac070 [DOI] [PubMed] [Google Scholar]
  • 53.Honório NA, Silva W da C, Leite PJ, Gonçalves JM, Lounibos LP, Lourenço-de-Oliveira R. Dispersal of Aedes aegypti and Aedes albopictus (Diptera: Culicidae) in an urban endemic dengue area in the State of Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2003;98(2):191–8. doi: 10.1590/s0074-02762003000200005 [DOI] [PubMed] [Google Scholar]
  • 54.Abdulai A, Owusu-Asenso CM, Akosah-Brempong G, Mohammed AR, Sraku IK, Attah SK, et al. Insecticide resistance status of Aedes aegypti in southern and northern Ghana. Parasit Vectors. 2023;16(1):135. doi: 10.1186/s13071-023-05752-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Owusu-Asenso CM, Mingle JAA, Weetman D, Afrane YA. Spatiotemporal distribution and insecticide resistance status of Aedes aegypti in Ghana. Parasit Vectors. 2022;15(1):61. doi: 10.1186/s13071-022-05179-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Seck MC, Thwing J, Fall FB, Gomis JF, Deme A, Ndiaye YD, et al. Malaria prevalence, prevention and treatment seeking practices among nomadic pastoralists in northern Senegal. Malar J. 2017;16(1):413. doi: 10.1186/s12936-017-2055-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Toé HK, Zongo S, Guelbeogo MW, Kamgang B, Viana M, Tapsoba M, et al. Multiple insecticide resistance and first evidence of V410L kdr mutation in Aedes (Stegomyia) aegypti (Linnaeus) from Burkina Faso. Med Vet Entomol. 2022;36(3):309–19. doi: 10.1111/mve.12602 [DOI] [PubMed] [Google Scholar]
  • 58.Baltzegar J, Vella M, Gunning C, Vasquez G, Astete H, Stell F, et al. Rapid evolution of knockdown resistance haplotypes in response to pyrethroid selection in Aedes aegypti. Evol Appl. 2021;14(8):2098–113. doi: 10.1111/eva.13269 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Hirata K, Komagata O, Itokawa K, Yamamoto A, Tomita T, Kasai S. A single crossing-over event in voltage-sensitive Na+ channel genes may cause critical failure of dengue mosquito control by insecticides. PLoS Negl Trop Dis. 2014;8(8):e3085. doi: 10.1371/journal.pntd.0003085 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013657.r001

Decision Letter 0

Clarence Mang'era

27 May 2025

Entomological surveys and the evolution of insecticide resistance in Aedes aegypti populations in Dakar, the capital city of Senegal: first detection of kdr mutation

PLOS Neglected Tropical Diseases

Dear Dr. Sene,

Thank you for submitting your manuscript to PLOS Neglected Tropical Diseases. After careful consideration, we feel that it has merit but does not fully meet PLOS Neglected Tropical Diseases's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within 60 days Jul 26 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosntds@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pntd/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Clarence Mang'era, PhD

Academic Editor

PLOS Neglected Tropical Diseases

Paul Mireji

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

Additional Editor Comments:

While your study addresses an important public health issue in Senegal with potential global impact, the manuscript requires extensive amendments in several key areas such as statistical analysis, ethical approval documentation and well supported conclusions to meet journal standards.

Journal Requirements:

1) Please ensure that the CRediT author contributions listed for every co-author are completed accurately and in full.

At this stage, the following Authors/Authors require contributions: Ndeye Marie Sene, Shirley Nimo-Paintsil, Moussa Gaye, El Hadj Ndiaye, El Hadji Malick Ngom, Babacar Diouf, Faty Amadou Sy, Moussa Moise Diagne, Alioune Gaye, Diawo Diallo, Ibrahima Dia, Scott C. Weaver, Samuel Dadzie, James F Harwood, and Mawlouth Diallo. Please ensure that the full contributions of each author are acknowledged in the "Add/Edit/Remove Authors" section of our submission form.

The list of CRediT author contributions may be found here: https://journals.plos.org/plosntds/s/authorship#loc-author-contributions

2) We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. If you are providing a .tex file, please upload it under the item type u2018LaTeX Source Fileu2019 and leave your .pdf version as the item type u2018Manuscriptu2019.

3) We do not publish any copyright or trademark symbols that usually accompany proprietary names, eg ©,  ®, or TM  (e.g. next to drug or reagent names). Therefore please remove all instances of trademark/copyright symbols throughout the text, including:

- TM on page: 44.

4) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines: 

https://journals.plos.org/plosntds/s/figures

5) Some material included in your submission may be copyrighted. According to PLOSu2019s copyright policy, authors who use figures or other material (e.g., graphics, clipart, maps) from another author or copyright holder must demonstrate or obtain permission to publish this material under the Creative Commons Attribution 4.0 International (CC BY 4.0) License used by PLOS journals. Please closely review the details of PLOSu2019s copyright requirements here: PLOS Licenses and Copyright. If you need to request permissions from a copyright holder, you may use PLOS's Copyright Content Permission form.

Please respond directly to this email and provide any known details concerning your material's license terms and permissions required for reuse, even if you have not yet obtained copyright permissions or are unsure of your material's copyright compatibility. Once you have responded and addressed all other outstanding technical requirements, you may resubmit your manuscript within Editorial Manager. 

Potential Copyright Issues:

- Figures 1 and 7. Please (a) provide a direct link to the base layer of the map (i.e., the country or region border shape) and ensure this is also included in the figure legend; and (b) provide a link to the terms of use / license information for the base layer image or shapefile. We cannot publish proprietary or copyrighted maps (e.g. Google Maps, Mapquest) and the terms of use for your map base layer must be compatible with our CC BY 4.0 license.

Note: if you created the map in a software program like R or ArcGIS, please locate and indicate the source of the basemap shapefile onto which data has been plotted.

If your map was obtained from a copyrighted source please amend the figure so that the base map used is from an openly available source. Alternatively, please provide explicit written permission from the copyright holder granting you the right to publish the material under our CC BY 4.0 license.

If you are unsure whether you can use a map or not, please do reach out and we will be able to help you. The following websites are good examples of where you can source open access or public domain maps:

* U.S. Geological Survey (USGS) - All maps are in the public domain. (http://www.usgs.gov)

* PlaniGlobe - All maps are published under a Creative Commons license so please cite u201cPlaniGlobe, http://www.planiglobe.com, CC BY 2.0u201d in the image credit after the caption. (http://www.planiglobe.com/?lang=enl)

* Natural Earth - All maps are public domain. (http://www.naturalearthdata.com/about/terms-of-use/).

6) We note that your Data Availability Statement is currently as follows: "All relevant data are within the manuscript and its Supporting Information files". Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data: 

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis..

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. 

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

7) Please ensure that the funders and grant numbers match between the Financial Disclosure field and the Funding Information tab in your submission form. Note that the funders must be provided in the same order in both places as well.

- State the initials, alongside each funding source, of each author to receive each grant. For example: "This work was supported by the National Institutes of Health (####### to AM; ###### to CJ) and the National Science Foundation (###### to AM)."

- State what role the funders took in the study. If the funders had no role in your study, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.".

If you did not receive any funding for this study, please simply state: u201cThe authors received no specific funding for this work.u201d

Reviewers' Comments:

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: Methods have many omissions making it difficult to assess robustness in several places. Statistical analyses limited or unclear and do not appear to support conclusions properly. Stated that no ethical review required

see main review for further comments

Reviewer #3: Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

The objective of the study are clearly articulated.

-Is the study design appropriate to address the stated objectives?

The study design is appropriate to address the objective.

-Is the population clearly described and appropriate for the hypothesis being tested?

The population is clearly described and appropriate for the hypothesis being tested.

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

The sample size is sufficient.

-Were correct statistical analysis used to support conclusions?

The statistical

-Are there concerns about ethical or regulatory requirements being met?

The ethical approval is required.

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: Results presentation generally ok though some amendments required and not all should be in main text or require modification

Reviewer #3: -Does the analysis presented match the analysis plan?

The analysis plan is good.

-Are the results clearly and completely presented?

The results are clear. There are sections that the author has mixed the methodogly and results. Section starting line 159 - 176

-Are the figures (Tables, Images) of sufficient quality for clarity?

The figures are of sufficient quality.

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: In my opinion some key conclusions are not well supported

No limitations are noted - but should be

Public health relevance needs clarification

Reviewer #3: -Are the conclusions supported by the data presented?

Yes

-Are the limitations of analysis clearly described?

No

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

Yes

-Is public health relevance addressed?

Yes

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: No very major changes are required

Reviewer #3: Entomological surveys and the evolution of insecticide resistance in Aedes aegypti

populations in Dakar, the capital city of Senegal: first detection of kdr mutation

Line 58 -68 Introduction section: There is a disconnect between the title and the manner in which the introduction starts. The authors start by describing dengue (one of the many viruses transmitted by Aedes disconnecting the reader from the title. It would be ideal if the authors started this section by describing the vector (as it is the primary focus of the study. This can then be followed by descriptions of infections and disease burdens associated with the vectors, challenges in control and description of the resistance mechanisms

Line 99- 102 – The use of etc should be avoided. Susceptibility is mis pelt

110 -Ethic statement – as a clarification shouldn’t a protocol undergo some form of scientific and ethical approval process prior to implementation?

Line 149- 150 – “Sentinel traps baited with a chemical Lure and CO2”. This is grammatically wrong.

Line 153 – “Resting mosquitoes were sampling using a Prokopack aspirator”. Correct this

Line 159 – 169 - the authors describe both methods and results (number of pools generated in this section and need to address grammatical errors for clarity. The same applies to lines 188-189 where the authors preempt the results in the methodology section

Line 256 table 1 Ovitrap indices– is there a reason why fewer ovitraps were placed in Ngor and Pikine and how did this influence the comparison between the sites

Line 153: Resting mosquitoes were "sampled" using a..........

Figure 6: Line no. 320-321 - The author should rephrase this sentence for clarity. "Phylogenetic relationship of newly generated DENV whole genomes from various serotypes and genotypes available in GenBank sequences and those previously available."

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: General comments

This paper contains useful data on entomological surveillance, phenotypic insecticide resistance, detection of arbovirus in mosquitoes and perhaps most significantly the detection of kdr mutations. However, the data are poorly analysed and without this conclusions are not well supported. Methods as presented are missing a lot of important details, precluding assessment of what was actually done and its robustness. The Discussion has many erroneous or misleading statements including misreporting of results from this and other studies, and apparent lack of understanding of how unusual the reported discoveries of the kdr mutations, which include Asian variants, are. Overall very substantial revision in all sections is required to bring this work to a publication standard.

Specific comments

Abstract

The study aim is stated as assessing risk of arbovirus transmission but there is nothing further in the abstract about how this study relates to this aim

Clarify that sampling was for one full year spanning 2022-2023; just giving the years could be read as meaning there were two full sampling years

Clarify that the total was 150 houses distributed among 15 neighbourhoods (i.e. 10 per neighbourhood, rather than 150 each)

It would be helpful to give an indication of insecticides tested and to which resistance detected

Some indication of conclusions or study significance would be useful in the abstract – some are present in the author summary but not currently in the abstract

Introduction

Line 79-80 could you give examples of the control methods used and when/where applied in Senegal, e.g. are they applied at specific outbreak times and locations? This would give helpful context.

Line 81-82 I am aware of two studies though the 2012 work was limited but you may wish to cite anyway since you say studies (plural) here. Also, would be helpful to give more detail here on what resistance was detected and to which types of insecticide, rather than saying reduced susceptibility which could be interpreted in different ways

Line 90 other mutations (V1016I and 410L) have also been detected in at least some of these neighbours. This is an important point to give context to your subsequent findings. Has the V410L every been looked for in Senegal?

Lines 91-92. I think it is worth noting here that the lack of detection comes from genotyping of a large number of samples in the cited study. This is important to emphasise that limited surveillance effort is a less likely explanation than low frequency

Line 93-94 I know this kind of statement is frequently made in publications, but to say it is essential for outbreak control given that pyrethroid resistance appears to be known already and is likely a suboptimal control solution seems an overstatement. Some context here is required to justify why this is important (e.g. the capacity of different kdr mutations to combine and elevate resistance or geographical variability in resistance (with respect to results in ref 7) that could mean that pyrethroids might be useful in some places, but spatiotemporal surveillance required and kdr mutation typing might help facilitate this).

Line 94, this is not true – coexistence of kdr mutations with metabolic resistance is well known especially in SE Asia – see e.g. review papers on Aedes aegypti resistance.

Line 102 suggests that such data are limited but not absent. Please cite relevant reference(s) or change wording if genuinely absent

Line 105 in the context of the way the study was performed here, what data would show a difference between host-seeking, resting and feeding behaviours? This needs some additional detail to specify assumptions with respect to the interpretation of the different collection methods.

Materials and Methods

Ethics: in many countries (including in Africa) this would now require ethical approval because it involves collections from households, which is regarded as human involvement. So I think it is essential that you clarify your statement here to say that this did not require ethical approval in Senegal (or Dakar, whichever is the case) to avoid giving the impression that this would be the case for this kind of work elsewhere.

Line 142 ‘lined with a wooden stick’ I think should read ‘included a wooden stick’

Line 147-148 why were ovitrap collections performed in 15 sites and adult collections in 6 - what was the rationale for this subset? Also, you should make it clear which district each site is in so that reader does not have to work this out from the figure or earlier text.

Line 150 was this a BG lure? If so, which one was used and how often were these replaced?

Line 150-151 how many houses per site and where was the outdoor trap located?

Line 155 where were outdoor collections made?

Line 156 what is the rationale for the pooling strategies (i.e. N=) and what is the purpose of the ‘other species’ pools given that these were not used for ABV detection?

Line 155-160 it is not stated how mosquitoes were killed, how quickly they were preserved nor what the preservation method was; for subsequent RNA extractions these are important details. Presumably also these were whole mosquitoes, rather than head/thorax or salivary gland dissections – add this for clarity.

Line 160 which arboviruses?

Line 163 and line was = were

Line 163-4 32 x 20 doesn’t equal the stated total of 613

Line 166 above it states that super-pools consisted of 20 pools but here says that consisted of 6-7 pools

Line 165 why were males included in the screening? I assume fed and unfed were treated separately to detect infected (maybe infectious) vs infectious females. Please clarify the rationale for the different groups used.

Line 173 dengue is not capitalised

Line 174 For virus detection by RT-PCR what thermal cycler was used and more importantly what threshold ct or cq value, and what were there positive controls (what strains and supplier)?

Line 175 flavivirus and alphavirus capitalised here but not in line 170

Line 182 is a reference website available for these recommendations?

Line 189 please give accession numbers

Line 175-176 It isn’t clear here or from anything preceding in the manuscript why this sequencing is being done. From reading the qPCR paper cited I think it is because the method just detects flaviviruses, unless it has been modified here. If this is correct, why was the alphavirus chikungunya used as a positive and why were subsequent pools tested for flavivirus and alphavirus. I’m not familiar with the Twist research panel and I suspect this will be the case for many readers. The link for reference 19 is dead but looking at the website the details are limited. More information is required here and citations to papers if available rather than just a website link. The method might be great, but I can’t assess this from the information I could find.

Line 193-207 please explain the rationale for the doses used. I can understand the lower doses which are Aedes aegypti standards now (and it is good that these are used) but the higher ones look like from 5X Anopheles intensity assays. I’m assuming the reason for this was based on paper availability, but this needs to be explained that these were being used as a way of looking at resistance intensity using available (rather than optimal) papers.

Line 194-195. In the abstract it states that females for testing were reared from collected eggs but this detail is omitted here. Did these come from ovitraps or collected blood fed females laying eggs? In either case, how many eggs were reared from each ovitrap or female’s brood i.e. how was it ensured that the tested cohorts were not composed of many siblings, which could impact the results? Also were all returned to the same laboratory for testing?

Line 201 should chlorpyrifos ethyl read methyl?

Line 204 when was knockdown recorded – at 1h?

Line 213-214 I am not necessarily questioning the validity of this but given the expectation of very low frequencies, leading to a lack of past detection, why were both resistant and susceptible chosen for genotyping (rather than just resistant, at least as an initial subset to determine whether mutations were present). Also why the sample was divided among the four pyrethroids – again, some explanation of rationale would be helpful

Line 212 This is an unusual choice for screening, given the previous lack of detection of the Asian kdr mutants (989P and 1016G) in West Africa, but the previous detection of 410L which as a standalone may be the most important kdr mutation in Aedes aegypti. Please provide a rationale for the choice.

Line 227 assuming ANOVA means the standard method based on the normal distribution, was this checked for?; please give details

Line 235 Please explain from what data these KDT values were calculated, Did you record KD data at 10 minutes intervals? If so, please clarify this in the description of KD recording data.

Results

Lines 244-45 Please provide definition of epidemiological weeks

Lines 247-53 this analysis compares variation between sites but does not incorporate temporal effects – I would suggest to instead use a GLM with time of collection (could be grouped to month or season if desired) and the location x time interaction to evaluate consistency of variation over time

Also, and especially given the huge amount of work quantifying the EDI, and that EDI data are presented in figure 2, some similar analysis here would be warranted

Table 1 – how do stars indicate significance – i.e. with respect to what? All seem significant except Guediawaye but the ODI for this site does not seem extreme. Is there some error here?

Table 2 is slightly confusing because in the text you refer to ‘remaining species’ but in the table to ‘other species’ and do not list those which are included in this category, even though in some cases frequencies are similar to Aedes and you have included them in the text. Given that the focus is on Aedes, why not just include Aedes in the table to make it more easily readable? It is almost always the case that Cx quinq will be the most common in collections in Africa but they are not subject to any an analysis so maybe just present the full data for all species as a supplement – all seem to have been identified, representing considerable effort so it seems a waste for these data not to be presented somewhere.

Line 274-280 I think something is missing in the description of statistics used because chi-square would only identify an overall difference (maybe relates to strange significance classifications in table 1 also); was some post hoc test used as well?

Line 281-284 figure 3 represents pooled data without associated statical support for the statement that all sites showed same peak of Aedes abundance – see comment above about statistical testing, or at least provide confidence limits

Line 288 - 303 statistical support required to support assertion of locality differences in indoor vs outdoor resting and host preference. Also, no detail of methodology for blood meal typing is provided in the Methods (I assume is Kent and Norris given the host species identified). The HBI for Medina is also unusually low. Some description of the adult sample sites and any variation among them would be useful in the Methods to help determine (if significantly lower) why this might be the case.

Lines 306-7 pool size does not appear to correspond that stated in Methods which for Aedes aegypti was stated as 20 per pool – for females this multiplier is close, but not exactly correct; for males it is not close

Line 308 which pools (male, female-fed, female-unfed) were positive? Also clarify how detected – RT-PCR or sequencing

Line 310-311 what does successfully serotyped as dengue 3 mean? Does this mean that the other two were some other serotype or not dengue? Clarity in what the RT-PCR method detects as positive may answer this question (see comment above). Also it seems strange that sequencing, which I would imagine would be highly sensitive, did not detect something in the positive pools. However, this is difficult to evaluate because of the lack of detail presented on the methods used.

Figure 6 legend. What does ‘Root-to-tip regression and time-scaled phylogenetic analysis show linear evolution between newly generated Dengue virus sequences obtained in Dakar (August-2022 to July-2023) and the other West African genotype sequences’ mean? Where is the time-scaling?

Line 333 please clarify what the actual intensity assays represented in terms of X – since these appear to be Anopheles higher dose papers but Aedes 1X papers they will not necessarily correspond to 5X and 10X

Fig 7 what does the size of the dot represent – is it mortality? Also the resistance threshold terminology needs aligning to that used in the text

Fig 8 which pyrethroid? Also the only text referring to this is the single sentence in 346-347 which refers to the KDT values but these are not shown, and the statement is obvious – that the values would be higher for diagnostic than higher doses. Unless there is some further analysis here, this figure is not worth inclusion, at least in the main text.

Line 367-368 how was this tested – on alleles or genotypes and what test was used? In the table the exact P-values should also be provided rather than P>0.1 for everything. It also appears that all sites and insecticides were tested separately but in the text it refers to pooled insecticides. The table is too large for inclusion in the main text and I would suggest to move to the supplement and provide here a reduced version which just shows the total of dead and alive with study sites pooled. Further investigation into associations is also required because the sample sizes are rather small to give well powered tests when subdivided as they are here.

Fig 9 is difficult to read and the order of loci stated in the legend is reversed with respect to thye axis labels. Maybe the genotypes could be ordered according to the number of resistant alleles present in the four locus genotype, and the resistant alleles indicated in a different colour in the axis labels to improve interpretability? It is also well demonstrated that the combination and number of resistant alleles across kdr loci is important for resistant – more so than single locus genotypes. Statistical testing of resistance association of the multilocus genotypes is required.

Discussion

Lines 415-418 I think some statistical support for variation in species diversity is required in the Results

Line 433 this sentence needs some context – why detection in four (of many) pools suggests substantial viral circulation

Line 440 migration of humans or mosquitoes?

Line 452 also agriculture

Line 455-457 it would be helpful here to give some more detail of how the monitoring can inform interventions

Line 459 this does not match the results reported – frequencies are not low and line 464 1016G is not absent (also at quite high frequency)

Lines 465-466 This is incorrect. None of these cited studies detected 989P and 1016G so the frequencies in Dakar were not lower. For two of the studies they definitely did not genotype for these mutants, and for the third, for which I could not access the full text, I would be surprised if they did but did not report absence. They did all screen for V410L though, which is a significant omission from this study

Line 467-470. This is wrong – these mutations can cause very high level resistance when in combination (see reviews or original Hirata paper). I guess what is referred to here is that association was not detected here but as noted in comments above, the statistical testing procedures need revisiting.

Line 470 similar low frequencies of what? This study also did not screen for S989P or V1016G

Line 471 study 7 showed overexpression of these genes but not resistance association. This was inferred indirectly from the lack of kdr mutations found and the presence of phenotypic resistance. Therefore this conclusion is not robust, especially now that kdr mutations have been detected. Lack of contribution of kdr mutations to resistance when multiple kdr alleles are detected would also be very surprising given the functional validation of these and multiple studies showing a strong contribution to resistance.

Line 493 1016I was not detected and detox genes were not examined in this study and whether they would have been overexpressed as they were in study 7 is speculation, especially given that the populations appear to have changed substantially with respect to kdr.

Reviewer #2: I have read with great interest this manuscript profiling the resistance of Aedes aegypti samples from Dakar to insecticides and assessing the bionomics of this species. However, some clarifications are needed to consider this manuscript for publication in PNTD.

Line 20 “Aedes. Aegypti”.

At the beginning of the sentence, you must write Aedes in full. Please correct it across the manuscript.

Lines 79-80. “Current emergency control measures rely primarily on insecticide-based strategies, particularly, pyrethroid adulticides”. There is an any reference supporting this?

Lines 94-97. “The coexistence of kdr mutations with an overexpression of detoxification enzymes, a phenomenon never observed elsewhere, could greatly undermine the effectiveness of pyrethroid insecticides, which currently constitute the primary vector control method”. I’m not sure that this is true. Please see Ishak et al., 2015; Ishak et al. 2017 https://pubmed.ncbi.nlm.nih.gov/25888775/; https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0005302

Ethic statement: The justification provides to explain the absence of ethical clearance is not clear enough since samples were collected in private settings.

Line 175. “Flavivirus” “Alphavirus” should be italicized.

Line 193. Authors collected samples or populations. This need to be clarified across the manuscript.

Line 209-214. These sentences need to be reformulated. Mosquitoes genotyped were dead and alive after exposure to insecticide. Please indicated the minimum number of dead and alive specimens analysed in each sample.

Line 264-266. “Aedes.”, “Mansonia.” And “Culex.”. Please remove the dot after the name of genus.

Line 266. How can the authors be sure this is An. gambiae from morphology?

Aspiration was done indoor and outdoor. It would be important to indicate the place outdoor.

I suggest also to test whether the number of Aedes collected outdoor vs indoor is significant different or not?

In the manuscript, the authors state that mosquitoes were collected at 7am and 7pm using the BG Sentinel trap. I have serious doubts that the Aedes mosquitoes considered to have been collected at night were really collected at night. I believe they were collected in the early morning between 5am and 7am.

Which lab susceptible reference strain was used? How much could the authors be confident for the quality of impregnated papers used?

In fig 7. What does tolerant mean?

What could explain the resistance of Ae. aegypti samples from Dakar to all insecticides tested including carbamates, organophosphates, and organochlorines? These composed are currently used in Dakar for Aedes or mosquitoes’ control? This need to be discussed in the manuscript.

Differences found in resting and biting patterns between sampling sites should be discussed.

Reviewer #3: This study provides a comprehensive assessment of the spatial distribution, seasonal dynamics, and insecticide resistance mechanisms of Aedes aegypti in Dakar. Key findings include the widespread presence of Ae. aegypti across all surveyed sites, with increased activity observed between August and October, coinciding with the rainy season and heightened risk of arbovirus transmission. The detection of dengue virus (DENV) in mosquitoes collected from September to December highlights ongoing viral circulation and potential outbreak risk during this period.

The investigation into insecticide resistance revealed that mosquito populations exhibited resistance to WHO-recommended diagnostic doses, which could compromise current control efforts. Although the identified kdr mutations (F1534C, V1016I/G, and S989P) were present at low frequencies, their existence suggests emerging resistance mechanisms that may intensify over time.

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Figure resubmission:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions.

Reproducibility:

?>

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013657.r003

Decision Letter 1

Clarence Mang'era

11 Sep 2025

Please submit your revised manuscript within 30 days Oct 11 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosntds@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pntd/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers '. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below.

Revised Manuscript with Track Changes Manuscript

Clarence Mang'era, PhD

Academic Editor

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

Additional Editor Comments :

Line 31. Kdr mutations should be fully written for the first time.

Line 33: Please use the lowercase "dengue."

Line 41: It would be helpful to briefly list the specific multiple resistance mechanisms that were detected here.

Lines 121-124. The coexistence of kdr mutations and metabolic resistance mechanisms has also been reported in sub-Saharan Africa (Montgomery et al., 2022)

Lines 130-131. The objective of this specific part of the study could be stated more explicitly for the reader.

Line 194. CO2 include a subscript

Line 216-217. “The mosquitoes were homogenized and used for RNA extraction and Blood Feeding Patterns”. This sentence is not clear.

Please clarify the quality/standard of the insecticide-impregnated papers used, including the justification of concentration values used.

The legend of Figure 3 is incomplete.

Table 4. The legend is incomplete. CC, PP, II, CF, FF, VI, Freq ….

Line 592-592. Could you specify which of the insecticides listed in line 591 are commonly used for household nuisance control in Dakar? A reference for this common usage would be ideal here.

For context, please include the approximate distance between your study sites in Dakar and the Niayes zone. Also, a brief note on the known dispersion capacity of Aedes mosquitoes would strengthen the discussion.

**********

Reviewers' comments:

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #2: (No Response)

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #2: (No Response)

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #2: (No Response)

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #2: (No Response)

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #2: (No Response)

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #2: No

Figure resubmission:

Reproducibility:

To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols-->?>

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013657.r005

Decision Letter 2

Clarence Mang'era

17 Oct 2025

Dear Dr. Sene,

We are pleased to inform you that your manuscript 'Entomological Surveys and Insecticide Resistance in the Dengue Vector Aedes aegypti in Dakar, Senegal: First Detection of the kdr Mutation' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Clarence Mang'era, PhD

Academic Editor

PLOS Neglected Tropical Diseases

Paul Mireji

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

***********************************************************

Please update the inset map to include the country name. Additionally, add a latitude and longitude scale to the main map to clearly indicate the geographic location of the study area.

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 16.0px; font: 14.0px Arial; color: #323333; -webkit-text-stroke: #323333}span.s1 {font-kerning: none

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013657.r006

Acceptance letter

Clarence Mang'era

Dear Dr. Sene,

We are delighted to inform you that your manuscript, "Entomological Surveys and Insecticide Resistance in the Dengue Vector Aedes aegypti in Dakar, Senegal: First Detection of the kdr Mutation," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Number of adult mosquitoes collected from August 2022 to July 2023 in Dakar.

    (DOCX)

    pntd.0013657.s001.docx (20.1KB, docx)
    S2 Table. Mean number of mosquitoes species collected per localities per month in Dakar from August 2022-July2023.

    (DOCX)

    pntd.0013657.s002.docx (13.3KB, docx)
    S3 Table. Knockdown times (KDT₅₀ and KDT₉₅, with 95% confidence intervals) of Aedes aegypti following exposure to different concentrations of pyrethroids across six localities in Dakar/ August 2022 to July 2023.

    (DOCX)

    pntd.0013657.s003.docx (17.3KB, docx)
    S4 Table. Number of genotypes and frequencies of kdr mutations in the VGSC gene of Aedes aegypti from six localities in Dakar.

    (DOCX)

    pntd.0013657.s004.docx (29.5KB, docx)
    Attachment

    Submitted filename: Reply to the editor and reviewers Comments.docx

    pntd.0013657.s006.docx (30.6KB, docx)
    Attachment

    Submitted filename: Point by point responses to Reviewer.docx

    pntd.0013657.s007.docx (30.6KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES